ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,163Medicare Part D Prescriptions Filled, Including Refills

Rank: 45 out of 1269

$763K Total Retail Price of All Prescriptions

Rank: 48 out of 1269

365 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
77% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maryland
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 365 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

2% of this provider’s 10,628 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$63 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maryland
FUROSEMIDE 638 566 1 5
POTASSIUM CHLORIDE 322 287 2 26
OMEPRAZOLE 313 290 3 8
METOPROLOL SUCCINATE 310 282 4 13
AMLODIPINE BESYLATE 277 242 5 2
SIMVASTATIN 253 229 6 3
LOSARTAN POTASSIUM 242 207 7 15
LEVOTHYROXINE SODIUM 236 183 8 4
TRAMADOL HCL 230 215 9 16
METOPROLOL TARTRATE 212 179 10 6
LACTULOSE 192 173 11 67
ATORVASTATIN CALCIUM 190 182 12 7
LISINOPRIL 188 153 13 1
DIOVAN 171 171 14 35
NEXIUM 171 145 14 41
PRAVASTATIN SODIUM 162 124 16 11
HYDRALAZINE HCL 158 147 17 48
METFORMIN HCL 151 118 18 9
ATENOLOL 145 133 19 14
HYDROCHLOROTHIAZIDE 142 119 20 10
DONEPEZIL HCL 141 141 21 22
CRESTOR 136 93 22 25
JANTOVEN 131 131 23 52
LANTUS 125 110 24 39
SERTRALINE HCL 125 99 24 23
ADVAIR DISKUS 121 96 26 46
WARFARIN SODIUM 120 113 27 12
CLONIDINE HCL 115 103 28 51
GLIMEPIRIDE 113 82 29 57
SPIRIVA 108 86 30 64
GABAPENTIN 106 89 31 17
DIGOXIN 105 87 32 62
ALLOPURINOL 105 88 32 49
ESCITALOPRAM OXALATE 102 92 34 58
CARVEDILOL 102 83 34 29
PREDNISONE 102 87 34 45
NAMENDA 101 101 37 38
CLOPIDOGREL 101 95 37 32
TAMSULOSIN HCL 97 84 39 31
ISOSORBIDE MONONITRATE ER 94 73 40 63
LEVOFLOXACIN 90 82 41 75
PLAVIX 81 77 42 47
HUMALOG 80 69 43 109
METOLAZONE 78 68 44 262
ALBUTEROL SULFATE 76 66 45 88
IBUPROFEN 73 50 46 73
IPRATROPIUM BROMIDE 73 73 46 127
RANITIDINE HCL 69 62 48 27
RISPERIDONE 69 69 48 43
CARBIDOPA-LEVODOPA 68 68 50 78
PANTOPRAZOLE SODIUM 66 58 51 18
LIDODERM 63 61 52 56
METOCLOPRAMIDE HCL 62 44 53 155
ALENDRONATE SODIUM 61 57 54 28
CEFUROXIME 61 51 54 171
PHENYTOIN SODIUM EXTENDED 60 28 56 137
VENTOLIN HFA 58 45 57 100
NOVOLOG 57 40 58 82
NITROGLYCERIN PATCH 57 56 58 114
CITALOPRAM HBR 57 54 58 21
HYDROCODONE-ACETAMINOPHEN 55 48 S3 61 20
MIRTAZAPINE 55 55 61 24
NISOLDIPINE 54 54 63 376
LISINOPRIL-HYDROCHLOROTHIAZIDE 54 49 63 33
ZOLPIDEM TARTRATE 54 52 63 19
AZITHROMYCIN 54 49 63 42
SPIRONOLACTONE 51 51 67 77
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 19, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.